We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AACC Rebrands to the Association for Diagnostics & Laboratory Medicine

By LabMedica International staff writers
Posted on 24 Jul 2023

The American Association for Clinical Chemistry (AACC, Washington, DC, USA) has announced a name change to the Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA). More...

The American Association for Clinical Chemistry (AACC, Washington, DC, USA) has announced a name change to the Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA). This change reflects the association's role as advocate and champion for a larger professional community involved in diagnostics and laboratory medicine, and its worldwide influence.

While the AACC has been a professional home for clinical chemists since its inception, its programs have over time appealed to a variety of specialties that operate within or alongside the clinical lab. As of today, the association broadly serves those working in or in cooperation with the clinical laboratory. The transition from AACC to ADLM was approved on April 21 through a member vote, in which over two-thirds majority favored the name change.

ADLM is committed to promoting better health via laboratory medicine. It unites over 70,000 clinical lab professionals, physicians, researchers, and business leaders worldwide. These individuals are engaged in various fields including clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other progressive laboratory sciences. Since 1948, ADLM has been instrumental in promoting the shared interests of the field by fostering programs that encourage scientific collaboration, knowledge, expertise, and innovation.

"I'm proud to say that this change has come about by listening to our members and focusing on the best way to ensure a bright future for our profession," said association president Dr. Shannon Haymond. "This name change does not represent a change of direction for the association. Instead, it more accurately reflects an evolution within the field and the association that has long been underway. As we evolve into this new branding, I'd like to emphasize that the goal of the new brand is to broaden our invitation to collaborate, not narrow it."

Related Links:
AACC 
ADLM 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
New
Respiratory Infections Test
STANDARD Q Adeno Respi Ag Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.